Modalis Therapeutics Corporation (TOKYO: 4883) today announced that its research article titled "Efficient LAMA1 gene ...
Discover why Elastic's unified AI platform drives enterprise value, with strong growth, major buyback, and acquisition ...
Pharmaceutical Technology on MSN
Alternative commercialisation models offer lifeline to future of gene therapies
Nonprofit founder and CEO, Craig Martin, notes that the industry will likely see more alternative gene therapy commercialisation models in the future.
In a CiOL interaction, Superteams.ai Founder Soum Paul breaks down enterprise AI adoption, fractional AI teams, governance ...
Andre Gelfi, IBJR Andre Gelfi, a board member and co-founder of the Brazilian Institute for Responsible Gaming (IBJR).
As AI-native infrastructure takes shape, enterprises are redesigning computing, data, and networking foundations to move ...
As artificial intelligence adoption grows across sectors, professionals who build expertise in machine learning and ...
The mood among ADA holders is currently one of extreme caution. On-chain metrics reveal that long-term investors realized losses exceeding $900 million in December alone. This scale of capitulation ...
Incognito is essentially a local privacy feature. It protects you from your spouse, not from Amazon. It doesn't natively ...
Approximately $1.71 billion in H1 2025 losses came from compromised wallets, compared to roughly $410 million from classic phishing attacks. Attackers don't need to "break" blockchains when they can ...
Explore how AI-driven anomaly detection enhances the security of Model Context Protocol (MCP) deployments, protecting AI infrastructure from evolving threats with real-time insights.
Based Detection, Linguistic Biomarkers, Machine Learning, Explainable AI, Cognitive Decline Monitoring Share and Cite: de Filippis, R. and Al Foysal, A. (2025) Early Alzheimer’s Disease Detection from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results